Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Kelly E. Dooley; Debra Hanna; Vidya Mave; Kathleen Eisenach; Radojka M. Savic

doi:10.1371/journal.pmed.1002842

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Kelly E. Dooley, Debra Hanna, Vidya Mave, Kathleen Eisenach, Radojka M. Savic

School of Medicine

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Original language	English (US)
Article number	e1002842
Journal	PLoS medicine
Volume	16
Issue number	7
DOIs	https://doi.org/10.1371/journal.pmed.1002842
State	Published - Jul 2019

ASJC Scopus subject areas

General Medicine

Access to Document

10.1371/journal.pmed.1002842

Cite this

@article{33a776e5669945ec90d7b2b85f8fea62,

title = "Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology",

author = "Dooley, {Kelly E.} and Debra Hanna and Vidya Mave and Kathleen Eisenach and Savic, {Radojka M.}",

note = "Funding Information: The authors received no specific funding for this work. Thanks to WHO for organizing the conference in Montreux and especially to Christian Lienhardt and Payam Nahid for their leadership in this effort.",

year = "2019",

month = jul,

doi = "10.1371/journal.pmed.1002842",

language = "English (US)",

volume = "16",

journal = "PLoS medicine",

issn = "1549-1277",

number = "7",

}

TY - JOUR

T1 - Advancing the development of new tuberculosis treatment regimens

T2 - The essential role of translational and clinical pharmacology and microbiology

AU - Dooley, Kelly E.

AU - Hanna, Debra

AU - Mave, Vidya

AU - Eisenach, Kathleen

AU - Savic, Radojka M.

N1 - Funding Information: The authors received no specific funding for this work. Thanks to WHO for organizing the conference in Montreux and especially to Christian Lienhardt and Payam Nahid for their leadership in this effort.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85069269208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069269208&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1002842

DO - 10.1371/journal.pmed.1002842

M3 - Review article

C2 - 31276490

AN - SCOPUS:85069269208

SN - 1549-1277

VL - 16

JO - PLoS medicine

JF - PLoS medicine

IS - 7

M1 - e1002842

ER -

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this